Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 14.4B | 27.2B | 13.7B | 14.7B |
Cost of revenue | 11.8B | 22.2B | 11.5B | 11.8B |
Gross profit | 2.6B | 5.0B | 2.2B | 2.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 398M | — | 385M | 429M |
Other operating expenses | 1.0B | 3.8B | 1.0B | 935M |
Operating income | 653M | 866M | 231M | 1.0B |
Non operating interest income | ||||
Income | 72M | 238M | 78M | 63M |
Expense | 65M | 335M | 69M | 74M |
Other income expense | — | — | — | — |
Pretax income | 667M | -361M | 270M | 1.0B |
Tax provision | 274M | -321M | 43M | 430M |
Net income | 393M | -40M | 227M | 619M |
Basic EPS | — | 0.1 | 0.1 | — |
Diluted EPS | — | 0.1 | 0.1 | — |
Basic average shares | — | 1.3B | 1.3B | — |
Diluted average shares | — | 1.3B | 1.3B | — |
EBITDA | 1.5B | 2.1B | 1.3B | 1.7B |
Net income from continuing op. | 667M | -631M | 270M | 1.0B |
Minority interests | -27M | 170M | -61M | 38M |
Preferred stock dividends | 0 | 0 | 0 | 0 |